Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 4, 2025 • 2:00 AM ET

Date/Time Source News Release
12/31/2024 10:15 AM EST PR Newswire TCBP Provides Update on Acquisition Strategy and Current Targets
12/30/2024 10:30 AM EST PR Newswire TCBP Issues 25% Stock Dividend
12/20/2024 08:30 AM EST PR Newswire TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients
12/18/2024 08:30 AM EST PR Newswire TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend
12/11/2024 07:00 AM EST PR Newswire TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy
12/04/2024 08:30 AM EST PR Newswire TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial
11/12/2024 09:30 AM EST PR Newswire TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant
10/30/2024 08:30 AM EDT PR Newswire TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements
10/25/2024 09:45 AM EDT PR Newswire TCBP Responds to False Social Media Claim
10/22/2024 08:30 AM EDT PR Newswire TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic
Page

Additional News

As of January 4, 2025 • 2:00 AM ET

Date/Time Source News Release
01/02/2025 08:30 AM EST InvestorBrandNetwork InvestorNewsBreaks - TC BioPharm Holdings PLC (NASDAQ: TCBP) Advances Negotiations for Strategic Acquisitions in Cell Therapy
12/30/2024 11:00 AM EST InvestorBrandNetwork InvestorNewsBreaks - TC BioPharm Holdings PLC (NASDAQ: TCBP) Shareholders Approve 25% Stock Dividend
12/20/2024 09:00 AM EST InvestorBrandNetwork InvestorNewsBreaks - TC BioPharm Holdings PLC (NASDAQ: TCBP) Reports Positive Safety Data in ACHIEVE Phase 2b Trial for AML and MDS/AML
12/18/2024 09:00 AM EST InvestorBrandNetwork InvestorNewsBreaks - TC BioPharm Holdings PLC (NASDAQ: TCBP) Announces Special Dividend for Shareholders Amid Ongoing Support
12/11/2024 08:30 AM EST InvestorBrandNetwork InvestorNewsBreaks - TC BioPharm Holdings PLC (NASDAQ: TCBP) and CareDx Collaborate to Enhance TCB008 Cell Therapy Development for AML
12/05/2024 08:30 AM EST InvestorBrandNetwork InvestorNewsBreaks - TC BioPharm Holdings PLC (NASDAQ: TCBP) Issues Update on ACHIEVE Clinical Trial
11/12/2024 10:00 AM EST InvestorBrandNetwork InvestorNewsBreaks - TC BioPharm Holdings PLC (NASDAQ: TCBP) Receives $250,000 Grant to Enhance TCB008 Manufacturing Efficiency
10/30/2024 09:00 AM EDT InvestorBrandNetwork InvestorNewsBreaks - TC BioPharm Holdings PLC (NASDAQ: TCBP) Updates Shareholders on Major Milestones, Expands Clinical Trial Sites and Secures $8M Funding in 2024
10/22/2024 01:48 PM EDT y%wire Shares of This Biotech Surge Following Collaboration Announcement For Monkeypox Research
10/22/2024 09:00 AM EDT InvestorBrandNetwork InvestorNewsBreaks - TC BioPharm Holdings PLC (NASDAQ: TCBP) Announces Collaboration for Monkeypox Treatment Development
Page